KYMERA THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
KYMERA THERAPEUTICS, INC. (KYMR) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -2.30% for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Expense Statement
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2024-02-22
- KYMERA THERAPEUTICS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -2.30%.
- KYMERA THERAPEUTICS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was -1.80%.
- KYMERA THERAPEUTICS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2021 was -5.10%.
- KYMERA THERAPEUTICS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2020 was -0.70%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month |
|---|---|
| 2023-12-31 | -2.30% 10-K · filed 2024-02-22 |
| 2022-12-31 | -1.80% 10-K · filed 2024-02-22 |
| 2021-12-31 | -5.10% 10-K · filed 2024-02-22 |
| 2020-12-31 | -0.70% 10-K · filed 2023-02-23 |
| 2019-12-31 | 0.00% 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |